...学大会（CIT2012）“最新试验与特色研究首次公布”专题会场上，主要研究者高润霖院士公布了Firehawk随机对照试验阶段（TARGET I）长支架队列主要终点数据。
基于1个网页-相关网页
最初的授证，是比传统系统更早的阶段受到认可，随机对照试验(rct)的临床信息的必要量，也比以前少。
An initial license is granted at an earlier stage than possible under the traditional system, with less clinical information from Randomized Controlled Trials (RCTs).
【译】近期手术疗效的随机对照试验，评价腹腔镜和开放的D3淋巴清扫术的阶段II / III期结肠癌：日本临床肿瘤学组的研究研究0404。
Short-term Surgical Outcomes From a Randomized Controlled Trial to Evaluate Laparoscopic and Open D3 Dissection for Stage II/III Colon Cancer: Japan Clinical Oncology Group Study JCOG 0404.
需要更进一步的随机对照试验，以确定在疾病每一个阶段中的治疗角色。
Further RCTs are needed to determine the role at each stage of disease.
应用推荐